Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Vicaut

Showing results (331-340 of 522) with videos related to

Pageof 53
Sort By:
Journal of Hepatology|June 28, 2011
Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosisGisèle N'Kontchou, Mounir Aout, Alexis Laurent, et al.
Shock (Augusta, Ga.)|December 19, 2012
Interleukin 10 antioxidant effect decreases leukocytes/endothelial interaction induced by tumor necrosis factor αOlivier Huet, Elisabette Laemmel, Yi Fu, et al.
Diabetes Care|May 9, 2023
GAD Antibodies in Women With Hyperglycemia in Pregnancy: No Association With Large-for-Gestational-Age Birth WeightElhadji Mamadou Moussa Thioye, Eric Vicaut, Etienne Larger, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 26, 2018
Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated HeparinJohanne Silvain, Stephen A O'Connor, Yan Yan, et al.
European Stroke Journal|January 28, 2020
Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokesPierre Amarenco, Jong S Kim, Julien Labreuche, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 19, 2021
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine DosesValérie Gounant, Valentine Marie Ferré, Ghassen Soussi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 4, 2018
Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysisJean-Philippe Collet, Mathieu Kerneis, Benoit Lattuca, et al.
Journal of the American College of Cardiology|April 25, 2015
Reply: Not All NSTEMIs Are Created EqualGilles Montalescot, Jean-Philippe Collet, Patrick Ecollan, et al.
Angiology|February 11, 2016
Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL TrialZhenyu Liu, Johanne Silvain, Mathieu Kerneis, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 23, 2024
Patterns of left ventricular remodeling post-myocardial infarction, determinants, and outcomeDamien Logeart, Yoann Taille, Geneviève Derumeaux, et al.
Pageof 53

Showing results (331-340 of 522) with videos related to

Sort By:
Pageof 53
Journal of Hepatology|June 28, 2011
Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosisGisèle N'Kontchou, Mounir Aout, Alexis Laurent, et al.
Shock (Augusta, Ga.)|December 19, 2012
Interleukin 10 antioxidant effect decreases leukocytes/endothelial interaction induced by tumor necrosis factor αOlivier Huet, Elisabette Laemmel, Yi Fu, et al.
Diabetes Care|May 9, 2023
GAD Antibodies in Women With Hyperglycemia in Pregnancy: No Association With Large-for-Gestational-Age Birth WeightElhadji Mamadou Moussa Thioye, Eric Vicaut, Etienne Larger, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 26, 2018
Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated HeparinJohanne Silvain, Stephen A O'Connor, Yan Yan, et al.
European Stroke Journal|January 28, 2020
Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokesPierre Amarenco, Jong S Kim, Julien Labreuche, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 19, 2021
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine DosesValérie Gounant, Valentine Marie Ferré, Ghassen Soussi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 4, 2018
Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysisJean-Philippe Collet, Mathieu Kerneis, Benoit Lattuca, et al.
Journal of the American College of Cardiology|April 25, 2015
Reply: Not All NSTEMIs Are Created EqualGilles Montalescot, Jean-Philippe Collet, Patrick Ecollan, et al.
Angiology|February 11, 2016
Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL TrialZhenyu Liu, Johanne Silvain, Mathieu Kerneis, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 23, 2024
Patterns of left ventricular remodeling post-myocardial infarction, determinants, and outcomeDamien Logeart, Yoann Taille, Geneviève Derumeaux, et al.
Pageof 53